QELBREE 100 mg/1
viloxazine hydrochloride · CAPSULE, EXTENDED RELEASE · Supernus Pharmaceuticals, Inc
QELBREE is a capsule, extended release containing viloxazine hydrochloride at 100 mg/1, taken oral. Manufactured by Supernus Pharmaceuticals, Inc.
Key Facts
- Brand Name
- QELBREE
- Generic Name
- viloxazine hydrochloride
- NDC Code (Product)
17772-131- Manufacturer
- Supernus Pharmaceuticals, Inc
- Strength
- 100 mg/1
- Dosage Form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- NDA211964
- Marketing Start
- 04/02/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is QELBREE used for?
QELBREE contains viloxazine hydrochloride. It is a capsule, extended release taken oral. Consult your doctor for specific uses.
Is QELBREE a controlled substance?
QELBREE is not classified as a controlled substance by the DEA.
What is the generic name for QELBREE?
The generic name for QELBREE is viloxazine hydrochloride. There are no other listed brand versions of viloxazine hydrochloride.
What is the NDC code for QELBREE 100 mg/1?
The NDC (National Drug Code) for QELBREE 100 mg/1 is 17772-131, listed by Supernus Pharmaceuticals, Inc.
Other QELBREE Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)